Premium
Internalization of Angiotensin‐(1‐12) in Adult Retinal Pigment Epithelial‐19 Cells
Author(s) -
Ahmad Sarfaraz,
Wright Kendra N.,
Ferrario Carlos M.,
Cheng HengJie,
Choudhary Mayur,
Malek Goldis,
Sappington Rebecca M.
Publication year - 2022
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2022.36.s1.l7802
Subject(s) - internalization , angiotensin ii , chemistry , monoclonal antibody , alexa fluor , microbiology and biotechnology , antibody , renin–angiotensin system , cytosol , biology , endocrinology , receptor , biochemistry , immunology , fluorescence , physics , quantum mechanics , blood pressure , enzyme
The characterization, by this laboratory, of angiotensin‐(1‐12) [Ang‐(1‐12)] as a primary angiotensin II (Ang II)‐forming substrate may be an unrecognized source of Ang II‐mediated microvascular complication in hypertension‐mediated retinopathy. We found that the plasma Ang‐(1‐12) level was 12‐66‐fold higher when compared to the angiotensin I in normal human subjects. For the first time, we investigated the endogenous expression and incorporation of Ang‐(1‐12) in cultured adult retinal pigment epithelial‐19 (ARPE‐19) cells. We also investigated the internalization of Ang‐(1‐12) in the presence of a highly specific monoclonal antibody (mAb) that was developed by us against the C‐terminus of the human Ang‐(1‐12) sequence. Method ARPE‐19 cells (passage 28‐30) were grown to post‐confluence in 10% serum supplemented DMEM/F12 medium for 2‐3 days. An immunofluorescence (IF) staining was performed to detect the internalized Ang‐(1‐12) using the human Ang‐(1‐12) mAb (1:5000 dilution) and the Alexa Flour 488 secondary antibody (1:1000 dilution). Internalization was also confirmed in ARPE‐19 using radiolabeled Ang‐(1‐12) [ 125 I‐Ang‐(1‐12), purity >99%] in the presence and absence of the mAb by HPLC. For this, the APRE‐19 cells were incubated (4 h) with Ang‐(1‐12) alone or Ang‐(1‐12) + mAb. Afterward, cells were washed and harvested in isotonic buffer. The lysed cells were centrifuged at 28,000 g and the membrane pellet and supernatants (cytosolic fractions) were counted on a gamma counter. The cytosolic fractions were further analyzed by HPLC using a C18 column to confirm the internalization of intact Ang‐(1‐12) sequence. Results Our IF staining shows that Ang‐(1‐12) is endogenously expressed in ARPE‐19 cells. Further, an increased intensity of staining was detected in ARPE‐19 cells exposed to Ang‐(1‐12) (100 nM). High Ang‐(1‐12) radiolabeled counts were detected in the cytosolic fractions (3.1% of the total loaded radiolabeled) and very low counts in the membrane pellet (0.2%). We found that the internalization of 125 I‐Ang‐(1‐12) was significantly decreased (~40%, P<0.0001) in the presence of the human Ang‐(1‐12) mAb (Fig. 1). The detection of a large peak (88%) of 125 I‐Ang‐(1‐12) in the cytosolic fraction in the HPLC chromatogram further confirms that the intact Ang‐(1‐12) sequence is internalized by the cells (Fig. 2). Conclusions Ang‐(1‐12) is internalized by ARPE‐19 cells from extracellular spaces of the retina and the internalization of Ang‐(1‐12) decreased following exposure to the human Ang‐(1‐12) mAb. Overall our data suggests the human Ang‐(1‐12) mAb may be used as a novel therapeutic agent to prevent circulating Ang‐(1‐12) internalization into the retinal cells and subsequently reduce the intracellular generation of the Ang II from the Ang‐(1‐12) substrate.